Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 542

Results For "IND"

6833 News Found

Vela Diagnostics launches NGS-based pan-cancer panels
Medical Device | March 28, 2022

Vela Diagnostics launches NGS-based pan-cancer panels

Vela Analytics can create concise, evidence-based in-house reports that help customers with the information to make timely, informed decisions about possible treatment options


Live Pharma Coalition organised its first-ever pharma conclave in Mumbai
News | March 28, 2022

Live Pharma Coalition organised its first-ever pharma conclave in Mumbai

It celebrated its 100th session as LPC-100 in association with Mundial Pharma


NTT DATA launches hackathon for AI innovations in healthcare
Digitisation | March 28, 2022

NTT DATA launches hackathon for AI innovations in healthcare

Registration is open for the global event that invites technology enthusiasts to bring innovative ideas to improve healthcare outcomes


New spesolimab data show promising results in patients with generalised pustular psoriasis flares
Biotech | March 28, 2022

New spesolimab data show promising results in patients with generalised pustular psoriasis flares

Clinical improvements were consistent across patient subgroups including age, gender, ethnicity, and IL-36 gene mutation status


ILC Dover launches liquid single-use bioprocessing bags for biotherapeutics market
Biotech | March 28, 2022

ILC Dover launches liquid single-use bioprocessing bags for biotherapeutics market

The company’s differentiated value proposition comes during a time of unprecedented disruption in the life science supply chain


NMPA approves Hansizhuang, its first monoclonal antibody
Drug Approval | March 27, 2022

NMPA approves Hansizhuang, its first monoclonal antibody

It also empowers domestic precision immunotherapy for tumours and promotes the high-quality development of China's biopharmaceutical industry


Phase 3 data show Dupixent improves signs and symptoms of prurigo nodularis
Biotech | March 27, 2022

Phase 3 data show Dupixent improves signs and symptoms of prurigo nodularis

There are currently no approved systemic treatments for prurigo nodularis; regulatory filings for prurigo nodularis planned in the first half of 2022


Aster DM Healthcare signs MoU with Tamil Nadu govt to invest Rs. 500 crore
Hospitals | March 27, 2022

Aster DM Healthcare signs MoU with Tamil Nadu govt to invest Rs. 500 crore

The MoU proposed investments in hospitals, pharmacies and laboratories in the state


ScienceMedia and Apex Mobile Clinical Research sign partnership for clinical trial training
Biotech | March 27, 2022

ScienceMedia and Apex Mobile Clinical Research sign partnership for clinical trial training

The implementation of ScienceMedia's solutions will ultimately help AMCR collapse patient recruitment and enrollment


NATHEALTH 8th annual summit in New Delhi from March 28-29.
News | March 26, 2022

NATHEALTH 8th annual summit in New Delhi from March 28-29.

More than 120 speakers and 5,000 delegates are expected to attend